Saturday 17 October 2026
Export PHG’s income statement to Excel — free account
Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.
25.74
0.25
+0.98%
Follow PHG
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
17.44 | 18.53 | 13.30 | 18.34 | 27.57 | 4.69 | 0.00 | 0.00 | 27.23 | 24.87 |
Piotroski F-Score |
7 | 6 | 7 | 5 | 6 | 4 | 3 | 5 | 5 | 7 |
P/S ratio |
1.02 | 1.63 | 1.16 | 1.33 | 1.78 | 1.34 | 0.61 | 0.87 | 1.22 | 1.27 |
Altman Z-Score |
2.25 | 2.93 | 2.62 | 3.10 | 3.07 | 2.17 | 1.25 | 1.61 | 1.71 | 1.98 |
Altman Z″-Score (non-manufacturers) |
2.71 | 3.30 | 2.81 | 2.93 | 2.91 | 2.64 | 1.69 | 1.67 | 1.70 | 2.10 |
P/FCF ratio |
23.33 | 22.97 | 12.62 | 14.98 | 12.69 | 9.58 | 0.00 | 0.00 | 0.00 | 44.24 |
Beneish M-Score |
(2.57) | (2.85) | (2.48) | (2.54) | (2.88) | (2.53) | (2.78) | (2.90) | (2.82) | (2.68) |
P/Operating CF |
23.41 | 87.62 | 18.06 | 24.51 | 19.99 | 30.17 | 37.61 | 58.01 | (267.60) | 16.23 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 55 |
P/B ratio |
1.85 | 2.49 | 2.33 | 3.17 | 3.50 | 2.04 | 1.02 | 1.61 | 1.84 | 2.07 |
Price to Tangible BV |
23.66 | 31.55 | 0.00 | 83.41 | 48.32 | 195.21 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.08 | 1.75 | 1.23 | 1.44 | 1.89 | 1.53 | 0.89 | 1.14 | 1.51 | 1.50 |
EV/EBITDA |
8.34 | 14.37 | 7.48 | 9.49 | 9.57 | 8.40 | 8.00 | 35.24 | 17.61 | 10.50 |
EV/Operating CF |
13.93 | 15.42 | 9.39 | 11.26 | 9.67 | 7.31 | 12.20 | 21.71 | 308.66 | 22.83 |
EV/FCF |
24.71 | 24.70 | 13.40 | 16.31 | 13.45 | 10.93 | (690.86) | (144.01) | (23.53) | 52.15 |
Quick Ratio |
0.77 | 0.88 | 0.80 | 0.88 | 0.99 | 0.85 | 0.71 | 0.71 | 0.84 | 0.86 |
Current Ratio |
1.34 | 1.47 | 1.21 | 1.36 | 1.45 | 1.39 | 1.29 | 1.20 | 1.23 | 1.32 |
Net Debt/EBITDA |
0.47 | 0.80 | 0.45 | 1.12 | 0.74 | 2.17 | 4.17 | 4.44 | 2.42 | 1.59 |
Debt/Assets |
12.45% | 15.97% | 13.17% | 18.28% | 20.59% | 20.91% | 23.69% | 23.92% | 24.55% | 25.73% |
Debt/Equity |
0.30 | 0.34 | 0.28 | 0.39 | 0.48 | 0.45 | 0.55 | 0.58 | 0.59 | 0.63 |
Asset Turnover |
0.77 | 0.62 | 0.72 | 0.72 | 0.72 | 0.59 | 0.54 | 0.61 | 0.62 | 0.65 |
Operating CF/Net income |
1.31 | 1.13 | 1.63 | 1.74 | 2.34 | 0.49 | 0.11 | (4.58) | (2.23) | 1.31 |
Capex/Depreciation |
(0.64) | (0.66) | (0.73) | (0.65) | (0.56) | (0.55) | (0.27) | (0.44) | (0.48) | (0.59) |
Interest Coverage |
3.31 | 5.77 | 6.51 | 7.06 | 7.56 | 2.94 | (5.92) | (0.31) | 1.37 | 4.12 |
| 11.43% | 13.13% | 9.23% | 9.19% | 9.78% | 25.56% | (10.89%) | (3.73%) | (5.82%) | 7.95% | |
| 4.57% | 5.82% | 4.34% | 4.29% | 4.38% | 11.50% | (4.91%) | (1.57%) | (2.40%) | 3.27% | |
ROIC |
7.85% | 6.74% | 8.02% | 6.37% | 6.75% | 1.86% | (4.96%) | (0.42%) | 1.98% | 5.91% |
Return on Tangible Assets |
25.15% | 34.22% | 32.62% | 21.83% | 19.23% | 59.31% | (32.40%) | (11.27%) | (16.22%) | 19.29% |
Average Days of Receivables |
81.60 | 82.48 | 84.24 | 88.64 | 80.46 | 84.40 | 88.80 | 79.41 | 88.15 | 73.47 |
Research and Development Expense of Revenue |
8.24% | 9.92% | 9.71% | 9.67% | 9.80% | 10.53% | 11.80% | 10.40% | 9.69% | 9.53% |
Selling, General and Administrative Expense of Revenue |
27.46% | 27.98% | 28.32% | 27.27% | 27.00% | 28.31% | 29.62% | 28.25% | 28.12% | 27.87% |
Intangible Assets out of Total Assets |
0.39 | 0.44 | 0.46 | 0.45 | 0.40 | 0.46 | 0.45 | 0.44 | 0.46 | 0.44 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.50% | 0.59% | 0.63% | 0.53% | 0.48% | 0.53% | 0.79% |
Graham Net Nets |
(0.19) | (0.11) | (0.15) | (0.12) | (0.12) | (0.22) | (0.55) | (0.39) | (0.34) | (0.27) |
Graham Number |
25.18 | 26.39 | 0.00 | 30.38 | 26.17 | 56.46 | 0.00 | 0.00 | 16.63 | 17.92 |
Earnings Yield |
5.73% | 5.40% | 7.52% | 5.45% | 3.63% | 21.30% | (20.07%) | (9.73%) | 3.67% | 4.02% |
Free Cash Flow Yield |
4.29% | 4.35% | 7.92% | 6.67% | 7.88% | 10.44% | (0.21%) | (0.91%) | (5.27%) | 2.26% |
Revenue per Share |
29.55 | 21.64 | 23.19 | 24.16 | 24.58 | 22.45 | 21.30 | 21.43 | 20.89 | 21.28 |
Operating CF per Share |
2.30 | 2.28 | 2.28 | 2.52 | 3.49 | 2.13 | (0.21) | 2.52 | 1.82 | 1.40 |
Capex per Share |
(1.00) | (0.83) | (1.02) | (1.21) | (1.16) | (0.96) | (0.94) | (0.65) | (0.77) | (0.79) |
Free Cash Flow per Share |
1.29 | 1.44 | 1.26 | 1.31 | 2.33 | 1.18 | (1.15) | 1.87 | 1.05 | 0.61 |
Cash per Share |
3.06 | 2.43 | 2.76 | 1.77 | 4.19 | 3.10 | 1.56 | 2.26 | 2.87 | 3.43 |
Shareholders Equity per Share |
16.28 | 14.63 | 15.50 | 15.66 | 14.98 | 18.94 | 15.87 | 14.23 | 13.96 | 13.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
16.28 | 14.63 | 15.50 | 15.66 | 14.98 | 18.94 | 15.87 | 14.23 | 13.96 | 13.11 |
Free Cash Flow |
1,187.38 | 1,340.54 | 1,160.92 | 1,179.36 | 2,116.68 | 1,063.61 | (1,012.51) | 1,712.20 | 980.38 | 580.41 |
Working Capital |
3,985.97 | 3,674.61 | 1,923.85 | 2,778.72 | 3,988.91 | 3,427.45 | 2,449.62 | 1,789.04 | 2,030.02 | 2,741.38 |
Capital Expenditures |
(919.58) | (773.13) | (941.26) | (1,095.36) | (1,055.49) | (863.66) | (830.24) | (599.59) | (717.43) | (745.59) |
Net Current Asset Value |
(5,223.16) | (3,588.70) | (5,113.73) | (5,523.84) | (5,237.45) | (7,263.05) | (7,529.03) | (8,014.43) | (7,478.39) | (6,813.30) |
EV/EBIT |
14.09 | 18.05 | 16.50 | 35.22 | 44.73 | 37.50 | 0.00 | 0.00 | 16.88 | 18.79 |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 |
Price to Operating Income |
13.30 | 16.79 | 15.54 | 32.37 | 42.21 | 32.86 | 0.00 | 0.00 | 13.62 | 15.94 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.60 | 0.65 | 0.64 | 0.52 | 0.62 | 0.50 | 1.12 | 0.51 | 0.57 | 0.51 |
Cash ROIC |
5.35% | 6.57% | 5.55% | 5.55% | 8.85% | 3.86% | (4.40%) | 7.53% | 4.19% | 2.47% |
Accounts Receivable Turnover |
4.63 | 3.79 | 4.51 | 4.26 | 4.37 | 4.22 | 4.06 | 4.45 | 4.34 | 4.60 |
Accounts Payable Turnover |
5.03 | 3.94 | 4.45 | 4.70 | 5.16 | 5.10 | 5.22 | 5.59 | 5.47 | 5.32 |
Inventory Turnover |
4.05 | 3.38 | 3.88 | 3.79 | 3.77 | 3.15 | 2.68 | 2.88 | 3.06 | 3.30 |
Average Days of Payables |
74.76 | 79.46 | 87.85 | 71.89 | 71.92 | 68.41 | 67.56 | 65.26 | 65.18 | 71.95 |
Days of Inventory on Hand |
89.04 | 89.46 | 102.01 | 95.42 | 101.59 | 126.08 | 138.99 | 118.85 | 113.90 | 107.16 |
Average Receivables |
5,861.94 | 5,303.41 | 4,740.24 | 5,118.83 | 5,108.73 | 4,806.05 | 4,631.41 | 4,423.90 | 4,493.82 | 4,385.51 |
Average Payables |
3,059.85 | 2,756.96 | 2,541.09 | 2,529.76 | 2,380.11 | 2,317.65 | 2,144.12 | 2,074.13 | 2,027.51 | 2,080.23 |
Average Inventory |
3,799.45 | 3,206.59 | 2,908.80 | 3,131.88 | 3,262.33 | 3,750.30 | 4,173.86 | 4,022.17 | 3,619.43 | 3,353.84 |
Average Assets |
35,071.13 | 32,180.03 | 29,671.00 | 30,493.18 | 30,957.24 | 34,143.26 | 34,481.42 | 32,079.50 | 31,590.52 | 30,919.69 |
Average Common Equity |
14,014.23 | 14,268.78 | 13,949.30 | 14,223.94 | 13,867.27 | 15,360.52 | 15,559.65 | 13,524.31 | 13,043.22 | 12,731.78 |
Columns are period end dates